Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

The Boston Globe Quotes Scientia Advisors in "Takeda's Millennium buy a boost for both"

Robert Weisman
April 12, 2011

In this Boston Globe article, Robert Weisman reflects on Takeda's acquisition model for Millennium. The author quotes Harry Glorikian, managing partner at Scientia Advisors: "The acquisition model pursued by Takeda, which Sanofi may be trying to imitate, is investing in a "center of excellence" that has the specialization and pipeline of products to drive the acquiring company's growth. In other deals a buyer may simply pull the acquired company's drugs into its own sales channel and then strip down the company to conserve cash. If there is a core competency at the company being acquired, it can attract further investment. That's what you've seen at Millennium. The other thing Millennium has going for it is the Boston area. It's a good place for Takeda to be. It's a place to attract talent."

Read the full article at: The Boston Globe